View Post

Elacestrant Benefit in Breast Cancer, but Compared to What?

In In The News by Barbara Jacoby

By:  M. Alexander Otto, PA, MMS From: .medscape.com Questions are now being asked about the comparator arm of a phase 3 trial in advanced breast cancer in which the investigational drug elacestrant (developed by Menarini/Radius Health) showed enough benefit for the companies to consider applying for approval from the US Food and Drug Administration. Elacestrant is a novel oral selective estrogen …